(b).
Variables | Group A Nonsignificant stenosis |
Group B Significant stenosis |
P value |
| |||
CAD risk factors (N, %) |
N = 91 (40%) | N = 136 (60%) | |
Gender | |||
Male | 68.0 (74.7%) | 110.0 (80.9%) | 0.269 |
Female | 23.0 (25.3%) | 26.0 (19.1%) | |
Obesity | 45.0 (49.5%) | 71.0 (52.2%) | 0.736 |
Hypertension (yes) | 54.0 (59.3%) | 84.0 (61.7%) | 0.842 |
DM (yes) | 40.0 (43.8%) | 65.0 (62.5%) | 0.008 |
Dyslipidemia (yes) | 28.0 (33.73%) | 41.0 (32.80%) | 0.885 |
Smoking (yes) | 30.0 (32.9%) | 63.0 (46.3%) | 0.062 |
FH of CAD (yes) | 22.0 (24.1%) | 40.0 (29.4%) | 0.465 |
Use antidiabetic treatment | 26.0 (28.6%) | 40.0 (38.1%) | 0.151 |
Use statin treatment | 25.0 (34.2%) | 38.0 (36.2%) | 0.224 |
Categorical variables were presented as number and percent. DM: type 2 diabetes, FH of CAD: family history of coronary artery diseases. Two-tailed P value is significant at <0.05.